Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

8.99
Delayed Data
As of Feb 27
 -0.19 / -2.07%
Today’s Change
7.09
Today|||52-Week Range
11.47
+8.31%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close9.18
Today’s open9.21
Day’s range8.80 - 9.21
Volume264,238
Average volume (3 months)331,709
Market cap$385.9M
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+107.85%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.74

Competitors

 Today’s
change
Today’s
% change
MRTXMirati Therapeutics ...-0.20-0.83%
ACRXAcelRx Pharmaceutica...-0.10-1.12%
RVNCRevance Therapeutics...-0.41-2.49%
SCLNSciClone Pharmaceuti...0.000.00%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMarch 11, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account